Transcription of COVID-19 vaccine safety update
{{id}} {{{paragraph}}}
National Center for Immunization & Respiratory DiseasesCOVID-19 vaccine safety updateAdvisory Committee on Immunization Practices (ACIP)March 1, 2021 Tom Shimabukuro, MD, MPH, MBACDC COVID-19 vaccine Task Force vaccine safety Team2 Disclaimer The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention (CDC) or the Food and Drug Administration (FDA).Mention of a product or company name is for identification purposes only and does not constitute endorsement by CDC or V-safe updateVaccine Adverse Event Reporting System (VAERS) updateVaccine safety Datalink (VSD) updateClinical Immunization safety Assessment (CISA) Project updateCOVID-19 vaccine safety in pregnancy451.
Acute myocardial infarction Vaccinated 1-21 days 21 30.8 N Appendicitis Vaccinated 1-21 days 25 53.5 N ell’s palsy Vaccinated 1-21 days 17 23.1 N Convulsions/seizures Vaccinated 1-21 days 10 9.4 N Disseminated intravascular coagulation Vaccinated 1-21 days 1 0 N Immune thrombocytopenia Vaccinated 1-21 days 1 0 N
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}